MB
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Prevalence of Post-COVID Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status | Clinical infectious diseases | 2023 | 75 | 57 | |||
SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of october 2020 to february 2021-implementation of swiss-wide diagnostic screening and whole genome sequencing | Microorganisms | 2021 | 149 | 141 | |||
Toscana virus meningitis case in Switzerland: an example of the ezVIR bioinformatics pipeline utility for the identification of emerging viruses | Clinical microbiology and infection | 2015 | 672 | 214 | |||
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn | The Pediatric infectious disease journal | 2013 | 666 | 3 | |||
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine | Antiviral therapy | 2012 | 592 | 6 | |||
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine | PloS one | 2012 | 705 | 301 | |||
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | 2012 | 656 | 0 | |||
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients | The oncologist | 2012 | 620 | 0 | |||
Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac disease | Journal of pediatric gastroenterology and nutrition | 2012 | 575 | 405 | |||
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 957 | 555 | |||
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children | Vaccine | 2011 | 581 | 0 | |||
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 790 | 8 |